Advantest Corporation (ADVANTEST) financials
JPX · Technology · Semiconductors · 7,241 employees · CEO Douglas Lefever
- Price
- $148.12 +2.5%
- Market cap
- $110B
- Enterprise value
- ¥17.2T Data as of 2026-11-21
- Last report
- Q2 '26 filed 2026-09-30
- Next report
- 2027-02-03 EPS est. ¥262.01
Valuation & key figures
- Market cap
- $110B Updated 49m ago
- Revenue
- ¥1.45T Trailing 12 months
- Revenue growth
- +65% FY2027 consensus
- Profit margin
- 39.6% Net income / revenue, TTM
- P/E
- 30.6× Forward 23.5× (FY2027)
- P/S
- 12.1× Price / sales, TTM
- EV / EBITDA
- 22.3× TTM
- Free cash flow
- ¥466B Trailing 12 months
- Net income
- ¥574B Trailing 12 months
- Revenue estimate
- ¥1.86T FY2027 consensus
- Earnings
- 2027-02-03 Revenue est. $3.04B · Updated 49m ago
- Dividend
- ¥49.00 Per payment · 2026-09-29
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-10-28): revenue beat by 10.4%, EPS beat by 27.5%Revenue ¥479B vs ¥434B expected (+10.4%); EPS ¥267.72 vs ¥210.05 (+27.5%).
- Revenue growth accelerating: 81.7% year on yearQ2 '26 revenue ¥478B, against an average of 36.0% over the four quarters before.
- Operating margin 50.0% (TTM), +10.6 pp on a year agoOperating income grew 88.0% while revenue grew 48.1%.
- Capex 2.5% of revenue (a year ago 2.9%)¥36.2B invested in the last 4 quarters (+26.6% on a year earlier). Free cash flow ¥466B = 81.2% of net income.
- Returned ¥193B to shareholders = 41.4% of free cash flowBuybacks ¥150B (a year earlier ¥120B), dividends ¥42.8B, stock-based pay ¥0 (TTM).
- Diluted share count down 0.9% in a year726M diluted shares in Q2 '26, 733M a year earlier.
- Net cash ¥295BCash + short-term investments ¥402B, debt incl. leases ¥107B; a year ago net cash ¥195B.
Last quarter: Q2 '26
Quarter ended 2026-09-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q2 '26 | Year ago | Change | |
|---|---|---|---|
| Revenue | ¥478B | ¥263B | +81.7% |
| Gross margin | 71.1% | 62.2% | +8.9 pp |
| Operating income | ¥267B | ¥108B | +146.2% |
| Operating margin | 55.8% | 41.2% | +14.6 pp |
| Net income | ¥193B | ¥79.6B | +142.7% |
| Diluted EPS | ¥266.23 | ¥108.69 | +144.9% |
| Operating cash flow | ¥170B | ¥93.1B | +82.5% |
| Capex | ¥11.6B | ¥12.7B | -8.3% |
| Free cash flow | ¥158B | ¥80.4B | +96.7% |
| R&D | ¥0 | ¥0 | – |
| Stock-based compensation | ¥0 | ¥0 | – |
Reported vs consensus
2026-10-28| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | ¥479B | ¥434B | +10.4% |
| EPS (as estimated) | ¥267.72 | ¥210.05 | +27.5% |
From the report of 2026-10-28 for Q2 '26: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyMargins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- ¥502B
- Capex
- -¥36.2B
- Buybacks
- -¥150B
- Dividends
- -¥42.8B
- Acquisitions
- -¥187B
- Net debt issued
- ¥121B
- Stock-based compensation
- ¥0
- Free cash flow
- ¥466B
- Returned to shareholders / FCF
- 41.4%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | 30.6× | 37.0× | 17.4× – 76.7× |
| EV / EBITDA | 22.3× | 23.0× | 11.6× – 45.1× |
| EV / Sales | 11.9× | 7.4× | 4.0× – 12.8× |
| Price / FCF | 37.6× | 108.1× | 17.8× – 394.3× |
| Price / Book | 15.3× | 10.3× | 6.2× – 18.6× |
| FCF yield | 2.7% | 2.6% | 0.3% – 5.6% |
| Return on invested capital | 40.4% | 26.8% | 12.7% – 42.6% |
| Return on equity | 62.7% | 31.7% | 14.4% – 47.2% |
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2027 | ¥1.86T | +64.8% | ¥1,030.86 | +100.8% | 23.5× | 21 |
| FY2028 | ¥2.52T | +35.6% | ¥1,405.14 | +36.3% | 17.3× | 22 |
| FY2029 | ¥3.11T | +23.2% | ¥1,760.34 | +25.3% | 13.8× | 20 |
| FY2030 | ¥3.21T | +3.2% | ¥1,823.00 | +3.6% | 13.3× | 9 |
| FY2031 | ¥3.45T | +7.8% | ¥1,964.55 | +7.8% | 12.3× | 10 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings.
Data as of 2026-11-21 · Amounts in JPY as reported; price and market cap in USD.